FDA Adverse Event Other Summary report: N

SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE

MDR report key: 1335865 · Received March 5, 2009

Report

Report Number
1220423-2009-00019
Event Type
Other
Date Received
March 5, 2009
Report Date
February 19, 2009
Manufacturer
GENZYME BIOSURGERY (SEPRAFILM/PACK)
Product Code
MCN
PMA / PMN Number
P950034
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

REPORT SOURCE LITERATURE DESCRIPTION. JOURNAL: GYNECOL ONCOL. AUTHOR: LEITAO JR MM, NATENZON A, ABU-RUSTUM NR, BROWN C, CHI DS, SONODA Y, LEVINE DA, GARDNER GJ, BARAKAT RR. TITLE: POSTOPERATIVE INTRA-ABDOMINAL COLLECTIONS USING A SODIUM HYALURONATE-CARBOXYMETHYLCELLULOSE BARRIER (HA-MC) AT THE TIME OF LAPAROTOMY FOR OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCERS. VOLUME: 112, YEAR: 2009, PAGES: 2 SUPPL 1. EVALUATION SUMMARY: NO SAMPLE WAS RETURNED AND NO LOT NUMBER WAS PROVIDED BY THE USER FACILITY , THEREFORE, GENZYME QUALITY ASSURANCE IS UNABLE TO PERFORM AN EVALUATION OR LOT HISTORY REVIEW. IF A LOT NUMBER IS PROVIDED IN THE FUTURE, THIS COMPLAINT WILL BE REOPENED AND THE APPROPRIATE INVESTIGATION WILL BE CONDUCTED.

Description of Event or Problem · 1

INTRA-ABDOMINAL FLUID COLLECTION [LOCALISED INTRAABDOMINAL FLUID COLLECTION]. CASE DESCRIPTION: LITERATURE-SPONT REPORT RECEIVED ON 19-FEB-2009 FROM A COMPANY REPRESENTATIVE REGARDING A FEMALE PATIENT OF UNK AGE AND INITIALS, WHOSE RELEVANT MEDICAL HISTORY INCLUDED AN UNK TYPE OF CANCER. THIS REPORT WAS RECEIVED FROM A LITERATURE ARTICLE ENTITLED "POSTOPERATIVE INTRA-ABDOMINAL COLLECTIONS USING A SODIUM. HYALURONATE-CARBOXYMETHYLCELLULOSE BARRIER (HA-CMC) AT THE TIME OF LAPAROTOMY FOR OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCERS". ON AN UNK DATE, THE PATIENT RECEIVED AN UNK NUMBER OF SHEETS OF SEPRAFILM DURING A LAPAROTOMY PROCEDURE. FOLLOWING THE PROCEDURE, THE PATIENT EXPERIENCED INTRA-ABDOMINAL FLUID COLLECTION WHICH REQUIRED DRAINAGE. IT WAS THE OPINION OF THE PHYSICIAN THAT THE SEPRAFILM WAS ASSOCIATED WITH THE DIAGNOSIS OF POST-OPERATIVE ABDOMINAL COLLECTION. AS OF THE DATE OF RECEIPT OF THIS REPORT, THE PATIENT OUTCOME WAS UNKNOWN. NO FURTHER INFORMATION WAS PROVIDED. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE BIORESORBABLE ADHESION BARRIER MCN GENZYME BIOSURGERY (SEPRAFILM/PACK) UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention